The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Shamir R. Mehta

Shamir R. Mehta MD

MSc, FRCPC

FACC, FESC, David Braley Cardiac

E-mail:

[email]@mcmaster.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Shamir R. Mehta MD, MSc, FRCPC, FACC, FESC, David Braley Cardiac, E-mail:. 2011
  • McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada. 2003 - 2010
  • Hamilton Health Sciences, General Division, 237 Barton Street East, McMaster Clinic, Canada. 2003
  • Division of Cardiology, the Population Health Research Institute and the Canadian Cardiovascular Collaboration Project Office, McMaster University, Hamilton, Canada. 2001 - 2002

References

  1. Clopidogrel in acute coronary syndromes: Where are we now? Bainey, K.R., Lai, T.F., Mehta, S.R. Thromb. Haemost. (2011) [Pubmed]
  2. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Mehta, S.R., Tanguay, J.F., Eikelboom, J.W., Jolly, S.S., Joyner, C.D., Granger, C.B., Faxon, D.P., Rupprecht, H.J., Budaj, A., Avezum, A., Widimsky, P., Steg, P.G., Bassand, J.P., Montalescot, G., Macaya, C., Di Pasquale, G., Niemela, K., Ajani, A.E., White, H.D., Chrolavicius, S., Gao, P., Fox, K.A., Yusuf, S. Lancet (2010) [Pubmed]
  3. Early versus delayed invasive intervention in acute coronary syndromes. Mehta, S.R., Granger, C.B., Boden, W.E., Steg, P.G., Bassand, J.P., Faxon, D.P., Afzal, R., Chrolavicius, S., Jolly, S.S., Widimsky, P., Avezum, A., Rupprecht, H.J., Zhu, J., Col, J., Natarajan, M.K., Horsman, C., Fox, K.A., Yusuf, S. N. Engl. J. Med. (2009) [Pubmed]
  4. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Mehta, S.R., Boden, W.E., Eikelboom, J.W., Flather, M., Steg, P.G., Avezum, A., Afzal, R., Piegas, L.S., Faxon, D.P., Widimsky, P., Budaj, A., Chrolavicius, S., Rupprecht, H.J., Jolly, S., Granger, C.B., Fox, K.A., Bassand, J.P., Yusuf, S. Circulation (2008) [Pubmed]
  5. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. Mehta, S.R., Bassand, J.P., Chrolavicius, S., Diaz, R., Fox, K.A., Granger, C.B., Jolly, S., Rupprecht, H.J., Widimsky, P., Yusuf, S. Am. Heart J. (2008) [Pubmed]
  6. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. Mehta, S.R., Granger, C.B., Eikelboom, J.W., Bassand, J.P., Wallentin, L., Faxon, D.P., Peters, R.J., Budaj, A., Afzal, R., Chrolavicius, S., Fox, K.A., Yusuf, S. J. Am. Coll. Cardiol. (2007) [Pubmed]
  7. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Mehta, S.R., Yusuf, S., Díaz, R., Zhu, J., Pais, P., Xavier, D., Paolasso, E., Ahmed, R., Xie, C., Kazmi, K., Tai, J., Orlandini, A., Pogue, J., Liu, L. JAMA (2005) [Pubmed]
  8. Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes. Mehta, S.R., Eikelboom, J.W., Demers, C., Maggioni, A.P., Commerford, P.J., Yusuf, S. Can. J. Physiol. Pharmacol. (2005) [Pubmed]
  9. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial. Mehta, S.R., Steg, P.G., Granger, C.B., Bassand, J.P., Faxon, D.P., Weitz, J.I., Afzal, R., Rush, B., Peters, R.J., Natarajan, M.K., Velianou, J.L., Goodhart, D.M., Labinaz, M., Tanguay, J.F., Fox, K.A., Yusuf, S. Circulation (2005) [Pubmed]
  10. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. Mehta, S.R., Cannon, C.P., Fox, K.A., Wallentin, L., Boden, W.E., Spacek, R., Widimsky, P., McCullough, P.A., Hunt, D., Braunwald, E., Yusuf, S. JAMA (2005) [Pubmed]
  11. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Mehta, S.R., Yusuf, S. J. Am. Coll. Cardiol. (2003) [Pubmed]
  12. Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE. Mehta, S.R. J. Invasive. Cardiol (2003) [Pubmed]
  13. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta, S.R. J. Invasive. Cardiol (2002) [Pubmed]
  14. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Mehta, S.R., Yusuf, S., Peters, R.J., Bertrand, M.E., Lewis, B.S., Natarajan, M.K., Malmberg, K., Rupprecht, H., Zhao, F., Chrolavicius, S., Copland, I., Fox, K.A. Lancet (2001) [Pubmed]
 
WikiGenes - Universities